[Federal Register Volume 84, Number 65 (Thursday, April 4, 2019)]
[Notices]
[Page 13308]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06571]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meeting will be open to the public to attend or dial-in, with 
in-person attendance limited to space available. Individuals who plan 
to attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should notify the 
Contact Person listed below in advance of the meeting.

    Name of Committee: National Cancer Institute Clinical Trials and 
Translational Research Advisory Committee; Translational Research 
Strategy Subcommittee (TRSS).
    Date: May 8, 2019.
    Time: 10:00 a.m. to 11:00 a.m.
    Agenda: Review the Glioblastoma (GBM) Working Group Report.
    Place: National Institutes of Health, Building 31, Room 11A01, 
31 Center Drive, Bethesda, MD 20892, (Join by Phone), 855-259-6342 
[Toll Free], Conference Code:1102766460, Passcode: 6460.
    Contact Person: Peter Ujhazy, MD, Ph.D., Deputy Associate 
Director, Translational Research Program, Division of Cancer 
Treatment and Diagnosis, National Institutes of Health, National 
Cancer Institute, 9609 Medical Center Drive. Room 3W106, Rockville, 
MD 20850, 240-276-5681, [email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page: http://deainfo.nci.nih.gov/advisory/ctac/ctac.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: March 29, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-06571 Filed 4-3-19; 8:45 am]
 BILLING CODE 4140-01-P